欢迎访问西亚试剂!
西亚试剂banner
西亚试剂banner
西亚试剂banner

当前位置:首页 > 新闻中心

西亚试剂:Non-Stem Cell Origin for Oligodendroglioma

发布时间:2025-08-22

Non-Stem Cell Origin for Oligodendroglioma
Anders I. Persson, Claudia Petritsch, Fredrik J. Swartling, Melissa Itsara, Fraser J. Sim, Romane Auvergne, David D. Goldenberg, Scott R. Vandenberg, Kim N. Nguyen, Stanislava Yakovenko, Jennifer Ayers-Ringler, Akiko Nishiyama, William B. Stallcup, Mitchel S. Berger, Gabriele Bergers, Tracy R. McKnight, Steven A. Goldman, William A. Weiss

Malignant astrocytic brain tumors are among the most lethal cancers. Quiescent and therapy-resistant neural stem cell (NSC)-like cells in astrocytomas are likely to contribute to poor outcome. Malignant oligodendroglial brain tumors, in contrast, are therapy sensitive. Using magnetic resonance imaging (MRI) and detailed developmental analyses, we demonstrated that murine oligodendroglioma cells show characteristics of oligodendrocyte progenitor cells (OPCs) and are therapy sensitive, and that OPC rather than NSC markers enriched for tumor formation. MRI of human oligodendroglioma also suggested a white matter (WM) origin, with markers for OPCs rather than NSCs similarly enriching for tumor formation. Our results suggest that oligodendroglioma cells show hallmarks of OPCs, and that a progenitor rather than a NSC origin underlies improved prognosis in patients with this tumor.

 

上一篇:N-(3-氯丙基)吗啉
下一篇:中国氢能联盟在北京宣告成立
版权所有:山东西亚化学有限公司

鲁ICP备20015914号-4